ESR1 and Parkinson disease: This sexual dimorphism may be related to estrogen receptors, which have been shown to inhibit proinflammatory cytokines (67), highlighting the need for preclinical studies in both sexes in diseases with an inflammatory component, either systemic or neurodegenerative, such as Parkinson’s disease (68).